Alpha Wealth Funds’s Inhibrx INBX Stock Holding History

Alpha Wealth Funds’s Portfolio INBX Stock Details INBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-38,647	Closed	-$541K	–	52
2025 Q1	$541K	Sell	38,647 -39,286	-50%	-$533K	0.55%	26
2024 Q4	$1.18M	Buy	+77,933	New	+$1.19M	1.14%	17

Other funds holding INBX

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Alpha Wealth Funds's INBX Position: Q2 2025 in Review

Alpha Wealth Funds sold out of Inhibrx (INBX) in Q2 2025, closing a stake of 38,647 shares — an estimated $541K sold.

Alpha Wealth Funds first reported a position in INBX in Q4 2024 and held it in 2 quarters. The position peaked at $1.18M in Q4 2024. 88 funds tracked by Wall St. Rank hold INBX as of Q2 2025.

Alpha Wealth Funds reported no remaining Inhibrx position as of Q2 2025 after selling out during the quarter.
Alpha Wealth Funds sold 38,647 Inhibrx shares in Q2 2025, an estimated $541K.
Alpha Wealth Funds first reported a position in Inhibrx in Q4 2024 and held it in 2 quarters.
Alpha Wealth Funds's Inhibrx position peaked at $1.18M in Q4 2024.
88 funds tracked by Wall St. Rank held Inhibrx as of Q2 2025.

Based on Alpha Wealth Funds's 13F filing for Q2 2025, filed 29 Jul 2025.